Glymphatic Dysfunction and Related Brain Structure Changes in Major Depressive Disorder: Effects of Glymphatic Function in Mediating Neuroinflammation
Open Access
- 25 May 2026
- journal article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (5) , 644-657
Abstract
Objective The glymphatic system, responsible for cerebrospinal fluid flow and waste clearance, is increasingly implicated in the pathophysiology of major depressive disorder (MDD) through its influence on neuroinflammation. This study investigated the association between glymphatic dysfunction, systemic inflammation, and brain volume changes in patients with MDD.Methods Glymphatic function was assessed using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) index in 176 patients with MDD and 178 controls. Inflammatory cytokine levels, including plasma C-reactive protein (CRP) levels, were measured in 68 patients with MDD and 54 controls. Depressive symptoms were evaluated using the Hamilton Depression Rating Scale. Statistical analyses included a multivariate analysis of covariance and Pearson’s partial correlations adjusted for covariates. Mediation analysis examined the relationships between CRP, glymphatic function, and brain volume.Results Patients with MDD showed reduced glymphatic function compared to healthy controls. Reduced DTI-ALPS indices were correlated with higher CRP levels and increased ventricular volumes, including the choroid plexus. CRP levels were negatively correlated with DTI-ALPS indices and right choroid plexus volumes. Mediation analysis indicated that glymphatic dysfunction partially mediated the relationship between elevated CRP levels and decreased choroid plexus volume in patients with MDD.Conclusion This study found that in MDD, glymphatic dysfunction is associated with higher CRP and mediates the link between systemic inflammation and right choroid plexus volume. Given sample size and limited covariate control, these results are preliminary and need confirmation in larger longitudinal cohorts. Even so, impaired glymphatic function may represent a therapeutic target.Keywords
Funding Information
- National Research Foundation of Korea (2020M3E5D9080792)
- National Research Foundation of Korea (2022R1A2C2093009)
- National Research Foundation of Korea (RS-2023-00241730)
- Ministry of Science and ICT, South Korea
This publication has 72 references indexed in Scilit:
- Neuroinflammation in the central nervous system: Symphony of glial cellsGlia, 2018
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United StatesJAMA Psychiatry, 2018
- Impairment of paravascular clearance pathways in the aging brainAnnals of Neurology, 2014
- Brain volume abnormalities in major depressive disorder: A meta‐analysis of magnetic resonance imaging studiesHuman Brain Mapping, 2009
- Regionally Localized Thinning of the Cerebral Cortex in SchizophreniaArchives of General Psychiatry, 2003
- Involvement of the choroid plexus in central nervous system inflammationMicroscopy Research and Technique, 2000
- High-resolution intersubject averaging and a coordinate system for the cortical surfaceHuman Brain Mapping, 1999
- Cortical Surface-Based AnalysisNeuroImage, 1999
- INTERLEUKIN 6, BUT NOT CILIARY NEUROTROPHIC FACTOR OR LEUKAEMIA INHIBITORY FACTOR, IS RESPONSIBLE FOR THE ACUTE PHASE RESPONSE TO TURPENTINE-INDUCED MYOSITISCytokine, 1998
- Scale for suicide ideation: Psychometric properties of a self-report versionJournal of Clinical Psychology, 1988